{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:17:43Z","timestamp":1767651463719},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,5,10]],"date-time":"2007-05-10T00:00:00Z","timestamp":1178755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2007,10,2]]},"DOI":"10.1007\/s00198-007-0387-z","type":"journal-article","created":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T10:12:39Z","timestamp":1178705559000},"page":"1531-1540","source":"Crossref","is-referenced-by-count":8,"title":["Effects of bisphosphonate treatment on bone repair under immunosuppression using cyclosporine A in adult rats"],"prefix":"10.1007","volume":"18","author":[{"given":"T.","family":"Matsunaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Shigetomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,10]]},"reference":[{"key":"387_CR1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0140-6736(00)03632-1","volume":"357","author":"PD Delmas","year":"2001","unstructured":"Delmas PD (2001) Osteoporosis in patients with organ transplants: a neglected problem. Lancet 357:325\u2013326","journal-title":"Lancet"},{"key":"387_CR2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(00)03641-2","volume":"357","author":"G Leidig-Bruckner","year":"2001","unstructured":"Leidig-Bruckner G, Hosch S, Dodidou P et al (2001) Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357:342\u2013347","journal-title":"Lancet"},{"key":"387_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00198-003-1532-y","volume":"15","author":"LM Vautour","year":"2004","unstructured":"Vautour LM, Melton LJ III, Clarke BL et al (2004) Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 15:160\u2013167","journal-title":"Osteoporos Int"},{"key":"387_CR4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/jlts.2003.50044","volume":"9","author":"JE Compston","year":"2003","unstructured":"Compston JE (2003) Osteoporosis after liver transplantation. Liver Transpl 9:321\u2013330","journal-title":"Liver Transpl"},{"key":"387_CR5","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2004-1978","volume":"90","author":"NM Maalouf","year":"2005","unstructured":"Maalouf NM, Shane E (2005) Osteoporosis after solid organ transplantation. J Clin Endocrinol Metab 90:2456\u20132465","journal-title":"J Clin Endocrinol Metab"},{"key":"387_CR6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.healun.2004.03.020","volume":"24","author":"A Cohen","year":"2005","unstructured":"Cohen A, Addonizio LJ, Lamour JM et al (2005) Osteoporosis in adult survivors of adolescent cardiac transplantation may be related to hyperparathyroidism, mild renal insufficiency, and increased bone turnover. J Heart Lung Transplant 24:696\u2013702","journal-title":"J Heart Lung Transplant"},{"key":"387_CR7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00198-004-1653-y","volume":"16","author":"SD Roe","year":"2005","unstructured":"Roe SD, Porter CJ, Godber IM et al (2005) Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism. Osteoporos Int 16:142\u2013148","journal-title":"Osteoporos Int"},{"key":"387_CR8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.tp.0000230130.50451.78","volume":"82","author":"S Akaberi","year":"2006","unstructured":"Akaberi S, Lindergrard B, Simonsen O et al (2006) Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function. Transplantation 82:749\u2013752","journal-title":"Transplantation"},{"key":"387_CR9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s002230001167","volume":"68","author":"S Epstein","year":"2001","unstructured":"Epstein S, Dissanayake IR, Goodman GR et al (2001) Effect of the interaction of parathyroid hormone and cyclosporine A on bone mineral metabolism in the rat. Calcif Tissue Int 68:240\u2013247","journal-title":"Calcif Tissue Int"},{"key":"387_CR10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00223-002-2147-6","volume":"73","author":"T Tsubone","year":"2003","unstructured":"Tsubone T, Shigetomi M, Ihara K et al (2003) Hypertrophy of vascularized bone isograft in rats treated with cyclosporine A. Calcif Tissue Int 73:393\u2013399","journal-title":"Calcif Tissue Int"},{"key":"387_CR11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/me.2004-0108","volume":"19","author":"O Bell","year":"2005","unstructured":"Bell O, Gaberman E, Kilav R et al (2005) The protein phosphatase calcineurin determines basal parathyroid hormone gene expression. Mol Endocrinol 19:516\u2013526","journal-title":"Mol Endocrinol"},{"key":"387_CR12","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1359\/jbmr.040912","volume":"19","author":"A Cohen","year":"2004","unstructured":"Cohen A, Sambrook P, Shane E (2004) Management of bone loss after organ transplantation. J Bone Miner Res 19:1919\u201332","journal-title":"J Bone Miner Res"},{"key":"387_CR13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMoa035617","volume":"350","author":"E Shane","year":"2004","unstructured":"Shane E, Addesso V, Namerow PB et al (2004) Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med 350:767\u2013776","journal-title":"N Engl J Med"},{"key":"387_CR14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-144-4-200602210-00005","volume":"144","author":"BA Crawford","year":"2006","unstructured":"Crawford BA, Kam C, Pavlovic J et al (2006) Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 144:239\u2013248","journal-title":"Ann Intern Med"},{"key":"387_CR15","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00198-006-0082-5","volume":"17","author":"F Atamaz","year":"2006","unstructured":"Atamaz F, Hepguler S, Akyildiz M et al (2006) Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation. Osteoporos Int 17:942\u2013949","journal-title":"Osteoporos Int"},{"key":"387_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.5650110102","volume":"11","author":"S Epstein","year":"1996","unstructured":"Epstein S (1996) Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 11:1\u20137","journal-title":"J Bone Miner Res"},{"key":"387_CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S8756-3282(97)00071-9","volume":"21","author":"DA Sass","year":"1997","unstructured":"Sass DA, Bowman AR, Yuan Z et al (1997) Alendronate prevents cyclosporin A-induced osteopenia in the rat. Bone 21:65\u201370","journal-title":"Bone"},{"key":"387_CR18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00223-001-1085-z","volume":"70","author":"S Zeni","year":"2002","unstructured":"Zeni S, di Gregorio S, Gomez AC et al (2002) Olpadronate prevents the bone loss induced by cyclosporine in the rat. Calcif Tissue Int 70:48\u201353","journal-title":"Calcif Tissue Int"},{"key":"387_CR19","doi-asserted-by":"crossref","first-page":"17130","DOI":"10.1073\/pnas.0508480102","volume":"102","author":"L Sun","year":"2005","unstructured":"Sun L, Blair HC, Peng Y et al (2005) Calcineurin regulates bone formation by the osteoblast. Proc Natl Acad Sci USA 102:17130\u201317135","journal-title":"Proc Natl Acad Sci USA"},{"key":"387_CR20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.devcel.2006.04.006","volume":"10","author":"MM Winslow","year":"2006","unstructured":"Winslow MM, Pan M, Starbunk M et al (2006) Calcineurin\/NFAT signaling in osteoblasts regulates bone mass. Dev Cell 10:771\u2013782","journal-title":"Dev Cell"},{"key":"387_CR21","doi-asserted-by":"crossref","first-page":"F285","DOI":"10.1152\/ajprenal.00415.2005","volume":"292","author":"L Sun","year":"2007","unstructured":"Sun L, Peng Y, Zaidi N et al (2007) Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. Am J Physiol Renal Physiol 292:F285\u2013F291","journal-title":"Am J Physiol Renal Physiol"},{"key":"387_CR22","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS et al (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1294\u20131301","journal-title":"J Clin Endocrinol Metab"},{"key":"387_CR23","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMc062268","volume":"355","author":"R Armamento-Villareal","year":"2006","unstructured":"Armamento-Villareal R, Napoli N, Panwar V et al (2006) Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis. N Engl J Med 355:2048\u20132050","journal-title":"N Engl J Med"},{"key":"387_CR24","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","volume":"14","author":"M Coco","year":"2003","unstructured":"Coco M, Glicklich D, Faugere MC et al (2003) Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 14:2669\u20132676","journal-title":"J Am Soc Nephrol"},{"key":"387_CR25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00223-002-2015-4","volume":"72","author":"SB Hornby","year":"2003","unstructured":"Hornby SB, Evans GP, Hornby SL et al (2003) Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats. Calcif Tissue Int 72:519\u2013527","journal-title":"Calcif Tissue Int"},{"key":"387_CR26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00198-004-1588-3","volume":"15","author":"M Glatt","year":"2004","unstructured":"Glatt M, Pataki A, Evans GP et al (2004) Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid. Osteoporos Int 15:707\u2013715","journal-title":"Osteoporos Int"},{"key":"387_CR27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/micr.1920150913","volume":"15","author":"M Shigetomi","year":"1994","unstructured":"Shigetomi M, Doi K, Kuwata N et al (1994) Experimental study on vascularized bone allografts for reconstruction of massive bone defects. Microsurgery 15:663\u2013670","journal-title":"Microsurgery"},{"key":"387_CR28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0140-6736(96)91458-0","volume":"347","author":"K Doi","year":"1996","unstructured":"Doi K, Kawai S, Shigetomi M (1996) Congenital tibial pseudoarthrosis treated with vascularised bone allograft. Lancet 347:970\u2013971","journal-title":"Lancet"},{"key":"387_CR29","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1016\/S0041-1345(98)00803-3","volume":"30","author":"GO Hofmann","year":"1998","unstructured":"Hofmann GO, Kirschner MH, Wagner FD et al (1998) Allogeneic vascularized transplantation of human femoral diaphyses and total knee joints: first clinical experiences. Transplant Proc 30:2754\u20132761","journal-title":"Transplant Proc"},{"key":"387_CR30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S8756-3282(01)00680-9","volume":"30","author":"L Merida","year":"2002","unstructured":"Merida L, Shigetomi M, Ihara K et al (2002) Effects of vitamin D analog, 22-oxa-1,25 dihydroxyvitamin D3, on bone reconstruction by vascularized bone allograft. Bone 30:422\u2013427","journal-title":"Bone"},{"key":"387_CR31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/01.TP.0000074992.49236.58","volume":"76","author":"T Ohno","year":"2003","unstructured":"Ohno T, Shigetomi M, Ihara K et al (2003) Skeletal reconstruction by vascularized allogenic bone transplantation: effects of statin in rats. Transplantation 76:869\u2013871","journal-title":"Transplantation"},{"key":"387_CR32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0736-0266(03)00182-7","volume":"22","author":"K Ikeda","year":"2004","unstructured":"Ikeda K, Shigetomi M, Ihara K et al (2004) Effects of cessation of immunosuppression on skeleton reconstructed by vascularized bone allograft in rats. J Orthop Res 22:388\u2013394","journal-title":"J Orthop Res"},{"key":"387_CR33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S8756-3282(02)00864-5","volume":"31","author":"IR Reid","year":"2002","unstructured":"Reid IR (2002) Relationships among body mass, its components, and bone. Bone 31:547\u2013555","journal-title":"Bone"},{"key":"387_CR34","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1210\/endo.137.6.8641176","volume":"137","author":"FJ Buchinsky","year":"1996","unstructured":"Buchinsky FJ, Ma Y, Mann GN et al (1996) T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia. Endocrinology 137:2278\u20132285","journal-title":"Endocrinology"},{"key":"387_CR35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bone.2003.05.003","volume":"34","author":"J Fukunaga","year":"2004","unstructured":"Fukunaga J, Yamaai T, Yamachika E et al (2004) Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506. Bone 34:425\u2013431","journal-title":"Bone"},{"key":"387_CR36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/bbrc.2000.4130","volume":"280","author":"LC Hofbauer","year":"2001","unstructured":"Hofbauer LC, Shui C, Riggs BL et al (2001) Effects of immunosuppressants on receptor activator of NF-\u03baB ligand and osteopotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 280:334\u2013339","journal-title":"Biochem Biophys Res Commun"},{"key":"387_CR37","first-page":"314","volume":"3","author":"S Mori","year":"2003","unstructured":"Mori S (2003) Fracture healing with anti-resorptive agents. J Musculoskelet Neuronal Interact 3:314\u2013316","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"387_CR38","first-page":"1609","volume":"87","author":"CD Morris","year":"2005","unstructured":"Morris CD, Einhorn TA (2005) Bisphosphonates in orthopaedic surgery. J Bone Joint Surg Am 87:1609\u20131618","journal-title":"J Bone Joint Surg Am"},{"key":"387_CR39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bone.2004.11.013","volume":"36","author":"M Nagashima","year":"2005","unstructured":"Nagashima M, Sakai A, Uchida S et al (2005) Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur. Bone 36:502\u2013511","journal-title":"Bone"},{"key":"387_CR40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00007890-198511000-00004","volume":"40","author":"R Wassef","year":"1985","unstructured":"Wassef R, Cohen Z, Langer B (1985) Pharmacokinetic profiles of cyclosporine in rats: influence of route of administration and dosage. Transplantation 40:489\u2013493","journal-title":"Transplantation"},{"key":"387_CR41","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1196\/annals.1346.032","volume":"1068","author":"R Tamler","year":"2006","unstructured":"Tamler R, Epstein S (2006) Nonsteroid immune modulators and bone disease. Ann N Y Acad Sci 1068:284\u2013296","journal-title":"Ann N Y Acad Sci"},{"key":"387_CR42","doi-asserted-by":"crossref","unstructured":"Tsuruoka S, Kaneda T, Maeda A et al (2007) Dosing time-dependent variation of bone resorption by cyclosporin A in rats\u2019 femurs. Eur J Pharmacol, DOI: 10.1016\/j.ejphar.2007.02.007","DOI":"10.1016\/j.ejphar.2007.02.007"},{"key":"387_CR43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/mi.6.4.4","volume":"6","author":"PH Stern","year":"2006","unstructured":"Stern PH (2006) The Calcineurin-NFAT pathway and bone: intriguing new findings. Mol Interv 6:193\u2013196","journal-title":"Mol Interv"},{"key":"387_CR44","doi-asserted-by":"crossref","unstructured":"Yeo H, Beck LH, McDonald JM et al (2007) Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation. Bone DOI: 10.1016\/j.bone.2007.02.017","DOI":"10.1016\/j.bone.2007.02.017"},{"key":"387_CR45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/bmj.39048.407928.BE","volume":"334","author":"P Perel","year":"2007","unstructured":"Perel P, Roberts I, Sena E et al (2007) Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 334:197\u2013200","journal-title":"BMJ"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-007-0387-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-007-0387-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-007-0387-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:00:49Z","timestamp":1558623649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-007-0387-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,10]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,10,2]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1007\/s00198-007-0387-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,10]]}}}